Time-of-flight MR angiography: comparison of 3.0-T imaging and 1.5-T imaging—initial experience
WA Willinek, M Born, B Simon, HJ Tschampa… - Radiology, 2003 - pubs.rsna.org
… Intracranial TOF MR angiograms were independently graded by two radiologists (HJ
Textor, HU) on coronal, transverse, and sagittal maximum intensity projections according to …
Textor, HU) on coronal, transverse, and sagittal maximum intensity projections according to …
Magnetic resonance imaging in the clinical diagnosis of Creutzfeldt-Jakob disease
A Schröter, I Zerr, K Henkel, HJ Tschampa… - Archives of …, 2000 - jamanetwork.com
Objective To evaluate the diagnostic usefulness of magnetic resonance imaging (MRI) in
the clinical diagnosis of Creutzfeldt-Jakob disease (CJD). Background Creutzfeldt-Jakob …
the clinical diagnosis of Creutzfeldt-Jakob disease (CJD). Background Creutzfeldt-Jakob …
Current clinical diagnosis in Creutzfeldt‐Jakob disease: identification of uncommon variants
…, A Schröter, K Henkel, HJ Tschampa… - Annals of …, 2000 - Wiley Online Library
According to the recently established molecular basis for phenotypic heterogeneity of sporadic
Creutzfeldt‐Jakob disease (CJD), six different phenotypes are characterized by the size …
Creutzfeldt‐Jakob disease (CJD), six different phenotypes are characterized by the size …
Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease
OBJECTIVES To describe the clinical presentation of patients with Alzheimer's disease (AD)
or dementia with Lewy bodies (DLB) who were suspected of having Creutzfeldt-Jakob …
or dementia with Lewy bodies (DLB) who were suspected of having Creutzfeldt-Jakob …
Creutzfeldt-Jakob disease: comparative analysis of MR imaging sequences
…, S Poser, B Meissner, HJ Tschampa… - American Journal …, 2006 - Am Soc Neuroradiology
… A recent study by Tschampa et al 11 confirmed thalamic involvement in patients with sCJD
on the basis of quantitative analyses of diffusion changes. Hyperintensities of the thalamus …
on the basis of quantitative analyses of diffusion changes. Hyperintensities of the thalamus …
MRI in the diagnosis of sporadic Creutzfeldt–Jakob disease: a study on inter-observer agreement
HJ Tschampa, K Kallenberg, H Urbach, B Meissner… - Brain, 2005 - academic.oup.com
According to the current WHO criteria, technical investigations included in the clinical diagnosis
of sporadic Creutzfeldt–Jakob disease (sCJD) are electroencephalogram (EEG) and CSF…
of sporadic Creutzfeldt–Jakob disease (sCJD) are electroencephalogram (EEG) and CSF…
Radiological assessment of Creutzfeldt-Jakob disease
HJ Tschampa, I Zerr, H Urbach - European radiology, 2007 - Springer
Creutzfeldt-Jakob disease is a rare fatal neurodegenerative disorder, characterized by
rapidly progressive dementia and neurological signs. There is a need for early and accurate …
rapidly progressive dementia and neurological signs. There is a need for early and accurate …
Pattern of cortical changes in sporadic Creutzfeldt-Jakob disease
HJ Tschampa, K Kallenberg… - American Journal …, 2007 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: High cortical signal intensity on diffusion-weighted (DW)
or fluid-attenuated inversion recovery (FLAIR) images is increasingly described in sporadic …
or fluid-attenuated inversion recovery (FLAIR) images is increasingly described in sporadic …
Brain Tumors: Full- and Half-Dose Contrast-enhanced MR Imaging at 3.0 T Compared with 1.5 T—Initial Experience1
C Krautmacher, WA Willinek, HJ Tschampa, M Born… - Radiology, 2005 - pubs.rsna.org
… Afterward, all images were read independently by two neuroradiologists (CKK and HJ
Textor, both with more than 10 years of experience with cerebral MR imaging). Readers were …
Textor, both with more than 10 years of experience with cerebral MR imaging). Readers were …
Positron emission tomography with [18F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD)
…, I Zerr, A Hertel, KF Gratz, A Schröter, HJ Tschampa… - Journal of …, 2002 - Springer
The aim of this study was to explore the sites of metabolic changes with [ 18 F]2-fluoro-2-desoxy-D-glucose
(FDG) and positron emission tomography (PET) in patients with Creutzfeldt-…
(FDG) and positron emission tomography (PET) in patients with Creutzfeldt-…